Skip to main content

Ancient Ice Cave Bacteria Show Resistance to Modern Antibiotics

A novel bacterium recovered from 5,000-year-old ice exhibited resistance patterns to modern antibiotics, which may offer insights into how drug resistance evolves.

Written byLaura Tran, PhD
| 2 min read
Image of the entrance to an ice cave in Romania.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Trapped within the ice, microbes pulse with life. Researchers venture into dark caves and bitter cold, looking for resilient microorganisms and their vast bioactive potential.

This group includes Cristina Purcarea, a microbiologist at the Institute of Biology Bucharest of the Romanian Academy, who aimed to isolate bacteria from cave ice and characterize their antibiotic resistance and other potential biotechnology uses.

In a new study, published in Frontiers in Microbiology, she and her team isolated a strain of Psychrobacter from a 5,000-year-old layer of ice in the Scărișoara Ice Cave.1 Using whole genome sequencing, the researchers found that this ancient bacterium harbored resistance to modern antibiotics, along with resistance-related genes and genes with the potential to kill other “superbugs.” These findings suggest that ancient genomes may help scientists gain deeper insights into the mechanisms behind antibiotic resistance.

The researchers traveled to the Scărișoara Ice Cave, where they drilled a 25-meter ice core. From this ancient ice sample, the team observed an orange- and pink-pigmented bacterial colony emerge, which they later purified and identified as Psychrobacter strain SC65A.3.

Genomic analysis revealed that the novel bacterium carried 45 genes associated with adaptation to low-temperature environments, enabling it to survive in the extreme cold. When the researchers examined its antibiotic resistance profile, they found that SC65A.3 was resistant to 10 of the 28 modern antibiotics tested. In total, the genome contained over 100 resistance-related genes.

Continue reading below...

Like this story? Sign up for FREE Microbiology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“Studying microbes such as Psychrobacter SC65A.3 retrieved from millennia-old cave ice deposits reveals how antibiotic resistance evolved naturally in the environment, long before modern antibiotics were ever used,” said Purcarea in a press release.

Beyond resistance, the researchers also investigated the bacterium’s potential to produce unique enzymes and antimicrobial compounds. Notably, they identified nearly 600 genes with unknown functions, suggesting a vast, untapped reservoir of novel biological mechanisms. The genome also contained 11 genes that may inhibit or kill other bacteria, fungi, and viruses.

Based on these findings, the researchers emphasized the potential of studying microbes from extreme environments, such as ice caves. “These ancient bacteria are essential for science and medicine,” Purcarea said.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Laura Tran, PhD

    Laura Tran is an Associate Editor, Content & Newsletters at The Scientist. She has a background in microbiology. Laura earned her PhD in integrated biomedical sciences from Rush University, studying how circadian rhythms and alcohol impact the gut. While completing her studies, she wrote for the Chicago Council on Science and Technology and participated in ComSciCon Chicago in 2022. In 2023, Laura became a science communication fellow with OMSI, continuing her passion for accessible science storytelling.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo